Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
FDA approval of Tagrisso for Stage III EGFR-mutated lung cancer by end of 2024?  | Binary | 5 | 7 months ago | ||
NICE recommends Tagrisso for Stage III EGFR-mutated lung cancer by Q1 2025? | Binary | 5 | 7 months ago | ||
Tagrisso's market share in EGFR-mutated lung cancer treatments by end of 2024 | Categorical | 5 | 7 months ago | ||
Annual revenue from Tagrisso for EGFR-mutated lung cancer by end of 2024 | Categorical | 5 | 7 months ago | ||
Number of countries approving Tagrisso for Stage III EGFR-mutated lung cancer by end of 2024 | Categorical | 5 | 7 months ago | ||
Tagrisso achieves $1 billion in sales for Stage III lung cancer by mid-2025? | Binary | 4 | 7 months ago |